Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10) (French, HTML)

View metadata and access the original French HTML file: Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-30

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.

Access original file